Showing results (11-20 of 38) with videos related to
Sort By:
Pageof 4
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 18, 2002
Autologous stem cell transplantation for small cell lung cancerJ Douglas Rizzo, Anthony D Elias, Patrick J Stiff, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 6, 2014
The graft-versus-myeloma effect: chronic graft-versus-host disease but not acute graft-versus-host disease prolongs survival in patients with multiple myeloma receiving allogeneic transplantationMichele L Donato, David S Siegel, David H Vesole, et al.Frontiers in Oncology|March 31, 2025
Next-generation sequencing guides diagnosis and treatment in a complex presentation of ALK-positive anaplastic large-cell lymphoma: a case reportTejasvini Vaid, Thomas S Gunning, Rachel Cohen, et al.ISRN Radiology|June 25, 2014
Assessment of Myocardial Contractile Function Using Global and Segmental Circumferential Strain following Intracoronary Stem Cell Infusion after Myocardial Infarction: MRI Feature Tracking Feasibility StudySabha Bhatti, Hussein Al-Khalidi, Kan Hor, et al.The American Journal of Managed Care|December 21, 2017
Real-world economic value of a 21-gene assay in early-stage breast cancerStanley E Waintraub, Donna McNamara, Deena Mary Atieh Graham, et al.Cancer|December 20, 2011
Post-treatment (not interim) positron emission tomography-computed tomography scan status is highly predictive of outcome in mantle cell lymphoma patients treated with R-HyperCVADAnthony R Mato, Jakub Svoboda, Tatyana Feldman, et al.Clinical Lung Cancer|May 9, 2017
Genomic Profiling of Advanced Non-Small Cell Lung Cancer in Community Settings: Gaps and OpportunitiesMartin E Gutierrez, Kelly Choi, Richard B Lanman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2002
Phase I trial of intravenous administration of PV701, an oncolytic virus, in patients with advanced solid cancersAndrew L Pecora, Naiyer Rizvi, Gary I Cohen, et al.Frontiers in Oncology|July 1, 2022
Reliability of Cell-Free DNA and Targeted NGS in Predicting Chromosomal Abnormalities of Patients With Myeloid NeoplasmsAndrew Ip, Alexandra Della Pia, Gee Youn Geeny Kim, et al.Leukemia & Lymphoma|February 1, 2011
A phase III study of anti-B4-blocked ricin as adjuvant therapy post-autologous bone marrow transplant: CALGB 9254Richard R Furman, Michael L Grossbard, Jeffrey L Johnson, et al.Pageof 4